Skip to content

Written by Sarah Collins · Every article cited · Reviewed on a schedule

How we source
PCOSguides

Is Creatine Safe With PCOS? What the Androgen Concern Actually Says

9 min read

Written by Sarah CollinsChecked against the 2023 International Evidence-Based Guideline for the Assessment and Management of PCOSLast reviewed Published

A registered dietitian and clinician review is being arranged for this site. Until this article carries a named reviewer, treat it as a well-sourced summary of published guidance — not as a substitute for advice about your own case.

The short answer

Creatine does not raise testosterone. The androgen fear traces to one small 2009 trial of 20 male rugby players showing a 56% DHT jump — a finding a 2025 12-week trial failed to replicate. Creatine does raise serum creatinine, a lab marker that can look like kidney trouble on paper without reflecting real damage.

Does Creatine Raise Testosterone or Cause Hair Loss?

Creatine has not been shown to raise total or free testosterone in any of the controlled trials reviewed here, including the single 2009 study that started the hair-loss concern in the first place. That trial followed 20 college-aged rugby players through three weeks of creatine loading and maintenance and found dihydrotestosterone (DHT) rose 56% after the loading phase and stayed roughly 40% above baseline during maintenance, with the DHT-to-testosterone ratio rising alongside it. Total testosterone itself did not change, even in that trial. This single study, in one small sample of one sport, is the entire evidence base behind “creatine raises androgens.” That distinction — an androgen you may already have too much of, versus a supplement rumoured to add to it — is exactly why this question deserves a direct answer rather than a cautious shrug.

Has the Rugby Study Replicated?

No — a 2025 randomised controlled trial designed specifically to test the hair-loss claim found none of the androgen or hair effects the original 2009 study reported. It followed 45 resistance-trained men for 12 weeks on 5 g of creatine monohydrate a day and measured total testosterone, free testosterone, DHT, the DHT-to-testosterone ratio, and direct hair-follicle outcomes — the first study to assess hair-follicle health directly. It found no significant differences between the creatine and placebo groups on any of them.

An earlier study looked at the acute hormonal response rather than resting levels and found that short-term creatine supplementation did not alter the growth hormone, testosterone or cortisol response to a single heavy resistance-training session. Across three separate trials spanning 2001, 2009 and 2025, exactly one found any androgen effect, and the most rigorous, most recent, and most directly targeted one did not.

Table 1 — every trial behind the creatine-and-androgens claim, compared directly.
TrialDesignPopulationAndrogen finding
Eijnde 2001Acute response to a single resistance-training sessionTrained males, short-term creatineNo change in growth hormone, testosterone or cortisol response
van der Merwe 20093 weeks, loading then maintenance, crossover20 college-aged rugby playersTestosterone unchanged; DHT up 56% after loading, DHT:T ratio up
Lak 202512 weeks, 5 g/day, parallel-group RCT, direct hair-follicle measurement45 resistance-trained menNo change in testosterone, DHT, DHT:T ratio, or hair-follicle outcomes

What Does Creatine Actually Do?

Creatine loading raises intramuscular phosphocreatine stores by roughly 20–40% within about a week, according to the safety and efficacy evidence summarised in the 2017 ISSN position stand — phosphocreatine being the fuel your muscles draw on first during the opening seconds of a hard, brief effort. That mechanism is why creatine improves high-intensity exercise capacity and supports greater gains in strength and lean mass when paired with training. It is an energy-substrate supplement acting inside muscle cells. It is not a hormone, and it does not act on the hormone pathways that drive PCOS-related androgen excess.

How Is Creatine Actually Dosed?

Two protocols dominate the trials cited above: a loading phase of about 20 grams a day, split into four 5-gram doses, for five to seven days, followed by a 3–5 gram daily maintenance dose; or skipping the loading phase entirely and taking 3–5 grams a day from the start, which reaches the same saturated muscle stores in three to four weeks instead of one. The 12-week hair-loss trial used the simpler protocol — a flat 5 grams a day, no loading phase — and still measured no androgen or hair effect at 12 weeks, which is the pattern most people actually use rather than the faster-loading one.

Does Creatine Cause Bloating or Water Retention?

Creatine’s water effect follows from the same 20–40% rise in intramuscular phosphocreatine and creatine content described above: water moves into muscle cells to accompany it, which is why some initial weight increase is common in the first couple of weeks of loading. That intracellular shift — not fat gain, and not the kind of fluid retention that shows up as visible bloating — is listed among creatine’s well-documented, non-harmful effects in the ISSN position stand. For anyone already tracking cyclical water retention as part of PCOS, it is worth knowing this is a separate, smaller, and predictable mechanism, not an unpredictable addition to it.

What Does It Not Do?

Creatine does not function as an androgen, has not reliably raised DHT outside the single 2009 trial discussed above, and is not regulated or marketed as a hormonal supplement anywhere in the sports-nutrition literature reviewed here. It also does not build muscle or improve performance by itself without training behind it — the effect is additive to exercise, not a substitute for it.

The Creatinine Confound: Why a Kidney Test Might Look Off

Creatine supplementation is well documented to raise serum creatinine modestly in some users, a byproduct of creatine’s own breakdown into creatinine — a point specifically flagged in the ISSN position stand so that clinicians do not misread it as kidney injury. A dedicated systematic review of creatine trials found no significant change in the more meaningful kidney-function markers — plasma urea and measured or estimated kidney function — across the studies it reviewed.

The catch is what those two facts mean together. Estimated glomerular filtration rate (eGFR), the number a standard blood panel actually reports, is calculated from serum creatinine. If you are taking creatine and have bloodwork done for an unrelated reason, a mildly elevated creatinine or a slightly reduced eGFR is something to flag to whoever ordered the test — not evidence of kidney damage on its own, and not something to hide either, since it changes how the result should be interpreted.

What Does This Mean Specifically for PCOS?

None of the three trials reviewed above — in rugby players, resistance-trained men, and a single-session hormonal-response study — tested creatine supplementation in women with PCOS specifically for androgen or hair effects, and that gap is worth naming rather than papering over.

What can be said honestly is mechanistic: creatine does not act on 5-alpha reductase, ovarian androgen production, or the adrenal pathways that drive PCOS-related hyperandrogenism, which is why a causal link is biologically implausible even without a PCOS-specific trial to rule it out directly. Given the added caution PCOS understandably brings to anything androgen-adjacent, the absence of a dedicated PCOS trial is worth knowing rather than assuming away.

That gap cuts both ways. It means the androgen fear circulating in PCOS communities is built on a study that was never about PCOS and has not replicated even in its original population — but it also means no one has specifically confirmed reassurance in women who already have clinically elevated androgens. Reasonable caution and an unproven risk are not the same claim, and the evidence above supports the first, not the second.

Who Should Be Cautious?

Anyone with existing kidney disease should discuss creatine with their prescriber before starting, since the reassuring renal-function data above — from the 2019 systematic review — comes from people with normal kidney function to begin with. High single doses can also cause mild gastrointestinal upset — cramping or loose stools — in some people, which usually resolves by splitting the dose across the day or dropping the loading phase and starting at a lower maintenance dose instead.

If you notice new hair thinning after starting creatine, it is worth having it evaluated for one of the other, better-documented causes of hair loss in PCOS — covered in PCOS hair loss — rather than assuming causation the trial evidence does not support. And if elevated androgens are already part of your picture, what counts as high testosterone is a useful baseline to have before starting any new supplement, creatine included.

You may see PCOS written as polyendocrine metabolic ovarian syndrome (PMOS), after a 2026 global consensus of more than 50 organisations renamed it. Nothing about the creatine evidence above changed with the name — this article uses PCOS because that is still what most readers search.

For the two other supplement questions that come up alongside this one in the supplements section: vitamin D is missed for a completely different reason than the androgen question here, and iron status is worth checking before starting any new supplement if fatigue is also part of your picture.

Frequently Asked Questions

Common questions

  • Does creatine cause hair loss in women?

    The evidence does not support this. The claim traces to one 2009 study in 20 male rugby players; a 2025 trial built specifically to test it, using direct hair-follicle measurements over 12 weeks, found no effect.
  • Does creatine raise testosterone?

    No controlled trial has shown creatine raises total or free testosterone, including the original 2009 study that reported a DHT increase — testosterone itself was unchanged even there.
  • Is creatine safe for women with PCOS?

    No PCOS-specific trial exists, but nothing in the broader safety literature — reviewed in the 2017 ISSN position stand — points to an androgen or hair-loss risk. Anyone with kidney disease should check with a prescriber first.
  • Does creatine affect kidney function tests?

    It can raise serum creatinine modestly, which is what eGFR is calculated from — so a panel taken while supplementing may show a mildly reduced eGFR without reflecting actual kidney damage. Flag your creatine use to whoever orders the test.
  • What dose of creatine is typically studied?

    Most trials use 3–5 g of creatine monohydrate a day for maintenance, sometimes preceded by a short loading phase of around 20 g/day split across the day for 5–7 days.
  • Should I stop creatine before a kidney function blood test?

    Not necessarily, but tell whoever orders the test that you take it, since creatine can modestly raise serum creatinine and eGFR without indicating kidney injury — that context changes how the result should be read.

More on this

Sources

  1. 1.van der Merwe J, Brooks NE, Myburgh KH. Three weeks of creatine monohydrate supplementation affects dihydrotestosterone to testosterone ratio in college-aged rugby players. Clin J Sport Med. 2009.
  2. 2.Lak M, Forbes SC, Ashtary-Larky D, et al. Does creatine cause hair loss? A 12-week randomized controlled trial. J Int Soc Sports Nutr. 2025.
  3. 3.Eijnde BO, Hespel P. Short-term creatine supplementation does not alter the hormonal response to resistance training. Med Sci Sports Exerc. 2001.
  4. 4.Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. 2017.
  5. 5.de Souza E Silva A, Pertille A, Reis Barbosa CG, et al. Effects of Creatine Supplementation on Renal Function: A Systematic Review and Meta-Analysis. J Ren Nutr. 2019.
  6. 6.Teede HJ, Khomami MB, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026.